Senores Pharmaceuticals Limited

Company Profile
Company Name Senores Pharmaceuticals Limited
Open Date 20-12-2024
Close Date 24-12-2024
Exchange BSE, NSE
Lot Size 38 Shares
Issue Price ₹372 to ₹391 per share
Issue Size 1,48,87,723 shares
Application Amount ₹ 14,858 – ₹ 1,93,154 (38 to 494 shares)
Recommendation Apply

Incorporation: Senores Pharmaceuticals Limited
was originally incorporated on December 26, 2017.
The company has its registered office in Ahmedabad,
Gujarat, India.
▪ Business Activity: The company is global research
driven pharmaceutical company engaged in
developing and manufacturing a wide range of generic
pharmaceutical products in the B2B segment
predominantly for the Regulated Markets across
various therapeutic areas and dosage forms.
▪ Human Resource: The company had 145 employees
as of Sep 30, 2024.

(Read more on the review)

Financial Summary in Cr

KPI’s FY 22 FY 23 FY 24 FY-25*
Revenue 14.17 35.34 214.52 362.04
EBITDA 1.95 12.67 41.59 89.15
Net Profit 0.99 8.43 32.71 47.89
RoCE 2.53% 13.76% 8.43% 10.55%
ROE 2.71% 18.53% 14.12% 5.68%
P/E 216.02 58.80 32.02 37.60

Tentative Timeline

Opening Date 20/12/2024
Closing Date 24-12-2024
Basis of Allotment 26-12-2024
Initiation of Refunds 27-12-2024
Credit of Shares to Demat 27-12-2024
Listing Date 30-12-2024

Objects of the Issue

Repayment/pre-payment, in full or in part, of certain borrowings availed by the Company.
Investment in the Subsidiary, namely, Havix, for repayment/pre-payment of certain borrowings.
Funding the working capital requirements of the Company
Investment in the Subsidiaries, namely, Senores Pharmaceuticals Inc. (“SPI”) and Ratnatris Pharmaceutical Private Limited (“Ratnatris”), to fund their working capital requirements.
Funding inorganic growth through acquisition and other strategic initiatives
Repayment/prepayment, in part or full, of certain of borrowings availed by the company. - For payment of interest accrued thereon; and - Step-down Subsidiaries, namely SS & L Beach Private Limited and Maldives Property Holdings Private Limited, including the payment of interest thereon through investment in such step-down Subsidiaries
Offer For Sale
General corporate purposes

Contact Information

Registered Office Senores Pharmaceuticals Limited 1101 to 1103, 11th floor, South Tower, ONE 42 oppositeJayantilal Park, Ambali Bopal Road, Ahmedabad,-380054
Phone +91-79-29999857
Email cs@senorespharma.com
Website https://senorespharma.com/

Registrar Details

Name Link Intime India Private Limited
Phone +91-22-4918 6270
Email senorespharma.ipo@linkintime.co.in
Website https://linkintime.co.in/mipo/ipoallotment.html

IPO Reservation

Anchor Investor Shares Offered 66,65,725 (45%)
QIB Shares Offered 44,43,817 (30%)
Retail Shares Offered 14,81,272 (10%)
NII (HNI) Shares Offered 22,21,909 (15%)
Total Shares Offered 1,48,12,723 (100%)

Shareholding Pattern

Share Holding Pre Issue (Promoters) 66.66%
Share Holding Post Issue (Promoters) 45.76%

Contact Us to Enable Your Success!